Silver Book Fact

Between 1988 & 1994 and 1999 & 2004, use of pharmacological lipid-lowering treatment increased from 11.7% to 40.8%. Low-density lipoprotein cholesterol control increased from 4.0% to 25.1% among those with
high low-density lipoprotein cholesterol.

Rosamond W, Flegal K, Furie K, Go A, et al. Heart Disease and Stroke Statistics- 2008 Update. Circulation. 2008; 117. http://circ.ahajournals.org/cgi/content/short/117/4/e25

Reference

Title
Heart Disease and Stroke Statistics- 2008 Update
Publication
Circulation
Publication Date
2008
Authors
Rosamond W, Flegal K, Furie K, Go A, et al
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Heart Failure Disease Management (DM) Program Reduces Hospitalizations and Overall Costs  
  • TAVR Success in sSAS Patients
    A study of severe symptomatic aortic stenosis (sSAS) patients who received transcatheter aortic valve replacement (TAVR) found 30-day mortality of 2.2% for those who were high risk of surgical mortality/inoperable,…  
  • Anti-platelet therapy stroke risk reduction
    Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.  
  • “Over the past thirty-five years, U.S. age-adjusted mortality from cardiovascular disease declined 50 percent. This marked reduction reflects advances in the prevention, diagnosis, and treatment of common cardiovascular conditions.”  
  • Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.